Effects of a Personalized or Generic Three-dimensional Tumoral Kidney Model on Patient Experience and Professional-patient Interactions, Before and After Partial Nephrectomy

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this clinical trial is to compare preoperative information and patient experience using a personalized versus a generic 3D printed models of patients' tumoral kidney before and after nephron-sparing surgery. The main outcome measure will be based on semi-structured interviews with the patient and the carers.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

⁃ Patients:

• Adult patients (≥ 18 years of age)

• Scheduled for surgical management by laparoscopic robotic-assisted partial nephrectomy (1st management for a unilateral or bilateral kidney tumor)

• Expressed consent for integration in the UroCCR database

• Expressed consent for participation in the Rein-3D Personalize study

• Patients affiliated or benefiting from social security system

⁃ Professionals:

• Professionals working with patients treated in the Urology, Andrology and Renal Transplant - Department of the Bordeaux University Hospital for at least two months prior to the implementation of 3D models

• Free, informed and signed consent

Locations
Other Locations
France
CHU de Bordeaux
RECRUITING
Bordeaux
Contact Information
Primary
Gaëlle MARGUE, Dr
gaelle.margue@chu-bordeaux.fr
00335 57 82 17 62
Time Frame
Start Date: 2024-05-28
Estimated Completion Date: 2027-06-15
Participants
Target number of participants: 39
Treatments
Active_comparator: personalized 3D kidney model
exchange time with the personalized 3D model of the kidney to be operated on as information support
Active_comparator: generic 3D kidney model
exchange time with the generic 3D model of the kidney to be operated on as information support
Related Therapeutic Areas
Sponsors
Leads: University Hospital, Bordeaux

This content was sourced from clinicaltrials.gov